Natasha E. Holmes
- Clinical Biochemistry top 0.5%
- Bacterial Identification and Susceptibility Testing 16
- Infectious Diseases top 1%
- Antimicrobial Resistance in Staphylococcus 21
- COVID-19 Clinical Research Studies 11
- SARS-CoV-2 and COVID-19 Research 8
- Pharmacology top 1%
- Drug-Induced Adverse Reactions 39
- Toxicology top 2%
- Pharmacovigilance and Adverse Drug Reactions 12
-
- Contact Dermatitis and Allergies 17
-
- Urticaria and Related Conditions 10
- Co-authors
- Benjamin P. HowdenPaul D. R. JohnsonJason A. TrubianoKyra ChuaPatrick G. P. CharlesWei GaoTony M. KormanElizabeth J. Phillips
- Journals
- Journal of Allergy and Clinical Immunology (9 papers)Clinical Infectious Diseases (6 papers)The Journal of Allergy and Clinical Immunology In Practice (6 papers)
- Partner nations
- AustraliaUnited StatesCanada
In The Last Decade
Natasha E. Holmes
105 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 131
- Clinical Biochemistry 452
- Infectious Diseases 1.1k
- Applied Microbiology and Biotechnology 95
- Pharmacology 708
- Toxicology 119
Countries citing papers authored by Natasha E. Holmes
This map shows the geographic impact of Natasha E. Holmes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Natasha E. Holmes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Natasha E. Holmes more than expected).
Fields of papers citing papers by Natasha E. Holmes
This network shows the impact of papers produced by Natasha E. Holmes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Natasha E. Holmes. The network helps show where Natasha E. Holmes may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Natasha E. Holmes, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 0 | |
| 9 | 2023 | 0 | |
| 10 | 2023 | 0 | |
| 11 | 2023 | 6 | |
| 12 | 2023 | 2 | |
| 13 | 2023 | 6 | |
| 14 | 2023 | 2 | |
| 15 | 2022 | 6 | |
| 16 | 2020 | 27 | |
| 17 | 2019 | 5 | |
| 18 | 2018 | 0 | |
| 19 | 2013 | 18 | |
| 20 | 2010 | 172 |
About Natasha E. Holmes
Natasha E. Holmes is a scholar working on Toxicology, Pharmacology, Applied Microbiology and Biotechnology, Infectious Diseases and Clinical Biochemistry, having authored 119 papers that have together received 2.2k indexed citations. Recurring topics across this work include Drug-Induced Adverse Reactions (39 papers), Antimicrobial Resistance in Staphylococcus (21 papers), Contact Dermatitis and Allergies (17 papers), Bacterial Identification and Susceptibility Testing (16 papers), Pharmacovigilance and Adverse Drug Reactions (12 papers), COVID-19 Clinical Research Studies (11 papers), Urticaria and Related Conditions (10 papers) and SARS-CoV-2 and COVID-19 Research (8 papers). The work is most often cited by research in Clinical Biochemistry (452 citations), Infectious Diseases (1.1k citations), Applied Microbiology and Biotechnology (95 citations), Pharmacology (708 citations) and Toxicology (119 citations). Natasha E. Holmes has collaborated with scholars based in Australia, United States and Canada. Frequent co-authors include Benjamin P. Howden, Paul D. R. Johnson, Jason A. Trubiano, Kyra Chua, Patrick G. P. Charles, Wei Gao, Tony M. Korman, Elizabeth J. Phillips, Sara Vogrin and Abby Douglas. Their work appears in journals such as Journal of Allergy and Clinical Immunology, Clinical Infectious Diseases, The Journal of Allergy and Clinical Immunology In Practice, Critical Care and Resuscitation and Journal of Clinical Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.